Olumiant (Baricitinib) Tablets 1 mg, 2 mg & 4 mg | Prescription Information & Guide

Description

Olumiant (Baricitinib) Tablets 1 mg, 2 mg & 4 mg | Prescription Information & Guide

What Is Olumiant (Baricitinib)?

Olumiant contains baricitinib, a Janus kinase (JAK) inhibitor that doctors prescribe for certain inflammatory and immune-related conditions. The current U.S. prescribing information lists indications for adults with moderately to severely active rheumatoid arthritis after an inadequate response to one or more TNF blockers, adults with severe alopecia areata, and certain hospitalized adults with COVID-19 who require supplemental oxygen or mechanical ventilation.

Olumiant Tablet Strengths

Olumiant comes in 1 mg, 2 mg, and 4 mg tablets. Your healthcare professional determines the appropriate strength and treatment schedule according to your diagnosis, medical history, response to treatment, kidney function, and other factors. Do not select a strength or change your dose without medical guidance.

Prescription Olumiant Through WeightMedsNY

Patients who want to explore prescription treatment options can contact WeightMedsNY for information about its prescription-medication services, subject to applicable prescribing, pharmacy, and dispensing requirements. A qualified healthcare professional should evaluate your medical history and determine whether baricitinib represents an appropriate treatment option.

About 50% of patients pay $0 per prescription of Olumiant, and 80% of patients pay less than $205.²

About 80% of patients pay $0 per prescription of Olumiant, and 90% of patients pay less than $3.²

About 70% of patients pay $0 per prescription of Olumiant, and 90% of patients pay less than $6.²

if you do not have prescription medication insurance coverage, or if your insurance does not cover Olumiant, you can expect to pay close to the list price shown above, plus any additional pharmacy charges depending on where you purchase your medicine.

Before requesting Olumiant, provide accurate information about your current medicines, medical conditions, allergies, previous treatments, and relevant laboratory results. Your healthcare professional can then assess whether treatment fits your individual needs.

Olumiant Prescription and Treatment Information

The FDA prescribing information recommends appropriate evaluations and immunizations before treatment. Healthcare professionals may monitor blood counts, liver enzymes, lipids, and other laboratory measures during therapy. Patients with certain blood-count abnormalities or kidney or liver impairment may require different treatment decisions or dosing.

Olumiant also carries a boxed warning for serious infections, mortality, malignancy, major cardiovascular events, and thrombosis. Serious infections, including tuberculosis, can occur during treatment. Blood clots and cardiovascular events also require careful consideration. Discuss your individual risks with your healthcare professional before starting treatment.

Why Choose a Prescription-Based Approach?

Prescription treatment gives patients an opportunity to discuss their symptoms and medical history with an appropriate healthcare professional before using baricitinib. A clinician can review potential benefits, risks, interactions, monitoring requirements, and alternative treatments.

If WeightMedsNY legally provides access to Olumiant in your location, you can contact the service to learn about its current prescription process, eligibility requirements, pricing, and fulfillment options. Do not purchase or use baricitinib without a valid prescription and appropriate medical supervision.

Get Information About Olumiant Today

If you are considering Olumiant 1 mg, 2 mg, or 4 mg tablets, speak with a qualified healthcare professional about whether the medication suits your condition. WeightMedsNY can provide information about its available prescription services where permitted, while your clinician makes the treatment decision.